Precision medicine in colorectal surgery: coming to a hospital near you

ANZ J Surg. 2019 Sep;89(9):995-996. doi: 10.1111/ans.15391.

Authors

Kasmira Wilson^{1

2}, Vignesh Narasimhan^{1

2}, Toan Pham^{1

2}, Atandrila Das^{1

2}, Robert Ramsay^{1

2}, Alexander Heriot^{1

2}

Affiliations

¹ Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
² The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

PMID: 31522479
DOI: 10.1111/ans.15391

No abstract available

Publication types

Historical Article

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Australia / epidemiology
Cetuximab / therapeutic use
Circulating Tumor DNA / blood
Circulating Tumor DNA / genetics
Colorectal Neoplasms / metabolism*
Colorectal Neoplasms / mortality
Colorectal Neoplasms / therapy
Colorectal Surgery / standards*
Colorectal Surgery / statistics & numerical data
Genomics / methods*
History, 21st Century
Hospitals
Human Genome Project / history*
Humans
Immunotherapy / methods
Microarray Analysis / methods
Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
Mutation
Neoadjuvant Therapy / methods
Precision Medicine / methods*
Predictive Value of Tests
Proto-Oncogene Proteins p21(ras) / metabolism

Substances

Antibodies, Monoclonal, Humanized
Circulating Tumor DNA
KRAS protein, human
pembrolizumab
Mitogen-Activated Protein Kinase Kinases
Proto-Oncogene Proteins p21(ras)
Cetuximab